Screening
Recent articles
Impaired molecular ‘chaperone’ accompanies multiple brain changes, conditions
Rare genetic variants in a protein-folding complex contribute to a spectrum of phenotypes that encompass brain malformations, intellectual disability, autism and seizures, according to a new “hallmark” study.
Impaired molecular ‘chaperone’ accompanies multiple brain changes, conditions
Rare genetic variants in a protein-folding complex contribute to a spectrum of phenotypes that encompass brain malformations, intellectual disability, autism and seizures, according to a new “hallmark” study.
A genetics-first clinic for catching developmental conditions early: Q&A with Jacob Vorstman
A new clinic is assessing children who have a genetic predisposition for autism and other neurodevelopmental conditions—sometimes before traits appear.
A genetics-first clinic for catching developmental conditions early: Q&A with Jacob Vorstman
A new clinic is assessing children who have a genetic predisposition for autism and other neurodevelopmental conditions—sometimes before traits appear.
New tablet-based tools to spot autism draw excitement — and questions
Handheld devices promise to bring autism detection home, but many researchers urge caution.
New tablet-based tools to spot autism draw excitement — and questions
Handheld devices promise to bring autism detection home, but many researchers urge caution.
Average autism diagnosis delayed by more than two years
The findings may explain why the average age at diagnosis has plateaued at 4 years old.
Average autism diagnosis delayed by more than two years
The findings may explain why the average age at diagnosis has plateaued at 4 years old.
Dietary changes ease traits in rare autism-linked condition
Early treatment with nutritional supplements and a high-protein diet forestalls some neurodevelopmental problems for children with BCKDK deficiency.
Dietary changes ease traits in rare autism-linked condition
Early treatment with nutritional supplements and a high-protein diet forestalls some neurodevelopmental problems for children with BCKDK deficiency.
Tempering tales of a new autism measure: A conversation with Thomas Frazier
The questionnaire, designed to screen children for autism, isn’t ready for clinical use without further validation, contrary to what some overblown newspaper headlines reported.
Tempering tales of a new autism measure: A conversation with Thomas Frazier
The questionnaire, designed to screen children for autism, isn’t ready for clinical use without further validation, contrary to what some overblown newspaper headlines reported.
DNA unwinder tied to social behaviors in mice, zebrafish
Blocking the enzyme, called TOP2A, in embryos makes the animals less inclined to seek companionship later in life.
DNA unwinder tied to social behaviors in mice, zebrafish
Blocking the enzyme, called TOP2A, in embryos makes the animals less inclined to seek companionship later in life.
Explore more from The Transmitter
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”